CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity-Reference-Cited by-同舟云学术

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

Published:2018-02 Issue:5 Volume:7 Page:e1424677
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Roman Aguilera Amelia¹,Lutzky Viviana P.¹,Mittal Deepak¹,Li Xian-Yang¹^ORCID,Stannard Kimberley¹,Takeda Kazuyoshi²^ORCID,Bernhardt Günter³^ORCID,Teng Michele W. L.⁴,Dougall William C.¹,Smyth Mark J.¹

Affiliation:

1. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

2. Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan

3. Institute of Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, Germany

4. Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

Funder

Cancer Council Queensland

National Health and Medical Research Council (NHMRC)

Deutsche Forschungsgemeinschaft (DFG)

Cancer Research Institute (CRI)

Prostate Cancer Foundation of Australia (PCFA)

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1424677

Reference32 articles.

1. New signals from the invasive front

2. Cancer Metastasis: Building a Framework

3. Control of Metastasis by NK Cells

4. Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy

5. DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD155 as an emerging target in tumor immunotherapy;International Immunopharmacology;2024-04

2. TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma;iScience;2023-12

3. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer;Life Sciences;2023-10

4. Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment;Cancers;2023-09-18

5. Study protocol for improving mental health during pregnancy: a randomized controlled low-intensity m-health intervention by midwives at primary care centers;BMC Nursing;2023-09-07